# Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based In Vitro Diagnostics :  Guidance for Stakeholders and Food and Drug Administration Staff - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/use-of-public-human-genetic-variant-databases-to-support-clinical-validity-for-genetic-and-genomic-based-in-vitro-diagnostics-guidance-for-stakeholders-and-food-and-drug-administration-staff/d566c877-a6de-457c-a6e7-df0e3cbbe1f9

> FDA guidance document: Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based In Vitro Diagnostics :  Guidance for Stakeholders and Food and Drug Administration Staff. Issue date: April 13, 2018. Get complete insights and analysis.

---

## Details

- Title: Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based In Vitro Diagnostics :  Guidance for Stakeholders and Food and Drug Administration Staff
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Center for Devices and Radiological Health
- Office URL: /offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
- Issue Date: 2018-04-13
- Last Changed: 2019-04-09
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-1233">FDA-2016-D-1233</a>

## Related Documents

- [Considerations for Design, Development, and Analytical Validation of Next Generation Sequencing (NGS) - Based In Vitro Diagnostics (IVDs) Intended to Aid in the Diagnosis of Suspected Germline Diseases:  Guidance for Stakeholders and Food and Drug Administration Staff](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-for-design-development-and-analytical-validation-of-next-generation-sequencing-ngs-based-in-vitro-diagnostics-ivds-intended-to-aid-in-the-diagnosis-of-suspected-germline-diseases-guidance-for-stakeholders-and-food-and-drug-administration-staff/23d92ad8-5a27-4cf3-986b-82cc58005afd)
- [Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not Individually Identifiable :  Guidance for Sponsors, Institutional Review Boards, and Food and Drug Administration Staff](https://www.globalkeysolutions.net/guidances/guidance-document/guidance-on-informed-consent-for-in-vitro-diagnostic-device-studies-using-leftover-human-specimens-that-are-not-individually-identifiable-guidance-for-sponsors-institutional-review-boards-and-food-and-drug-administration-staff/11476245-87f7-47f1-9524-579d0dd12cae)
- [Administrative Procedures for CLIA Categorization:  Guidance for Industry and Food and Drug Administration Staff](https://www.globalkeysolutions.net/guidances/guidance-document/administrative-procedures-for-clia-categorization-guidance-for-industry-and-food-and-drug-administration-staff/f0ea1c64-f301-46d7-871d-775a1df357e5)